United States  

Is Moderna Stock Really Headed to $112?

Motley Fool Tuesday, 19 May 2020
Wall Street analysts are cranking up their price targets on the biotech in response to early clinical trial results for its coronavirus vaccine candidate.
0
shares
ShareTweetSavePostSend
 
Video Credit: The Street - Published
News video: Stocks Soar on Moderna Vaccine Optimism: What Wall Street’s Saying

Stocks Soar on Moderna Vaccine Optimism: What Wall Street’s Saying 01:52

The Dow closed 911 points higher and Moderna's stock surged 20%.

You Might Like


Related videos from verified sources

Wall Street drops as investors lose confidence [Video]

Wall Street drops as investors lose confidence

A wave of late-day jitters hit the stock market on Tuesday, as investors focused on a report questioning early-stage trial results for a possible coronavirus vaccine. Conway G. Gittens has the market..

Credit: Reuters Studio     Duration: 02:08Published

Related news from verified sources

Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says

Moderna will spike another 25% from current levels after encouraging progress on coronavirus vaccine, Goldman says
· *Goldman Sachs lifted its price target for Moderna stock to $105 from $63 on Monday after first trials for its coronavirus drug showed "encouraging"...
Business Insider Also reported by •Proactive InvestorsMotley Fool

Moderna Stock Rally Loses Steam Over COVID-19 Vaccine Worries

Shares of biotechs racing to make coronavirus vaccines, including Moderna Inc., fell about 10% on Wednesday, as investor concerns grew about the prospects of the...
Newsmax Also reported by •MarketWatchMotley FoolProactive Investors

Why Moderna Stock Plunged Today

The biotech leader is selling stock, leading some investors to take their profits off the table.
Motley Fool Also reported by •MarketWatch

Tweets about this